Probiotec Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,116.60
120.30
505.60
321.60
1,816.10
Total Accounts Receivable
9,648.40
8,339.40
8,695.00
10,822.10
16,472.10
Inventories
11,684.50
9,881.60
9,118.20
9,753.80
11,560.40
Other Current Assets
117.50
3,320.70
290.60
469.40
12,777.30
Total Current Assets
22,567.10
21,662.00
18,609.50
21,367.00
42,625.90
Net Property, Plant & Equipment
51,827.90
27,220.90
26,726.40
26,641.90
29,620.80
Intangible Assets
24,822.30
18,436.40
18,816.60
18,811.60
18,324.00
Total Assets
104,490.70
73,007.40
69,173.30
71,121.50
93,657.50
ST Debt & Current Portion LT Debt
15,039.00
12,788.80
6,444.60
4,394.50
6,209.10
Accounts Payable
11,298.70
8,266.10
7,283.90
8,450.80
10,939.00
Income Tax Payable
893.00
409.00
-
-
546.30
Other Current Liabilities
2,919.90
2,795.20
3,681.60
3,237.80
6,182.50
Total Current Liabilities
30,150.60
24,259.00
17,410.00
16,083.20
23,876.80
Long-Term Debt
2,535.90
2,274.70
1,013.10
3,057.30
8,713.20
Provision for Risks & Charges
550.30
452.50
559.80
668.30
150.10
Deferred Taxes
1,660.10
701.90
1,534.90
2,445.10
4,757.40
Other Liabilities
-
-
-
-
726.80
Total Liabilities
40,170.30
33,376.20
25,538.60
26,554.70
41,311.10
Common Equity (Total)
64,320.40
39,631.20
43,634.70
44,566.70
52,346.30
Total Shareholders' Equity
64,320.40
39,631.20
43,634.70
44,566.70
52,346.30
Total Equity
64,320.40
39,631.20
43,634.70
44,566.70
52,346.30
Liabilities & Shareholders' Equity
104,490.70
73,007.40
69,173.30
71,121.50
93,657.50

About Probiotec

View Profile
Address
83 Cherry Lane
Melbourne Victoria (VIC) 3026
Australia
Employees -
Website http://www.probiotec.com.au
Updated 07/08/2019
Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. It operates through the following segments: Branded Pharmaceuticals, Contract Manufacturing, Obesity and Weight Management, Europe, and Specialty Products. The Branded Pharmaceuticals segment involves the sale of branded pharmaceutical products.